EGFR-IN-186 is a potent EGFR inhibitor with an IC50 value of 0.065 µM. It also exhibits inhibitory activity against EGFRL858R (IC50= 0.528 µM) and EGFRT790M (IC50= 0.465 µM). EGFR-IN-186 induces apoptosis by increasing levels of Bax and caspase-3, while decreasing the expression of Bcl-2. This compound can be utilized in non-small cell lung cancer (NSCLC) research.
Target:
EGFR|||Apoptosis|||Caspase|||Bcl-2 Family
* VAT and and shipping costs not included. Errors and price changes excepted
